Vir Biotechnology, Inc.
VIR· Nasdaq
Released Aug 3, 2023, after the close
10-Q filed Aug 4, 2023, 35 days after period end · 0001628280-23-027527
| Metric | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|---|
| Revenue | $3.80M | -$40.63M | $177.07M | $66.99M |
| Net Income | -$194.78M | -$76.49M | $61.81M | -$31.17M |
| EPS Diluted |
Vir Biotechnology, Inc. · CIK 1706431 · Engraved from SEC EDGAR
| -$1.45 |
| -$0.58 |
| $0.46 |
| -$0.27 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.